Renal news roundup from AKF

Machine learning-driven risk prediction models can identify early indicators of chronic kidney disease (CKD) more accurately than traditional methods, according to a study in Methods of Information in Medicine. The study reveals gradient boosting as the most effective model, achi...

Vertex Pharmaceuticals' drug for immunoglobulin A (IgA) nephropathy has shown promising results in a Phase III trial, reducing a key disease marker by half. The drug, acquired through a $4.9 billion deal, matches the performance of Otsuka's recently approved Voyxact and surpasses...

People who have had COVID-19 are at nearly five times the risk for kidney failure compared with those who had influenza, according to a study in Communications Medicine. Researchers found that people who have recovered from COVID-19 are at 4.7 times the risk for kidney failure, 2...

Urate-lowering therapy (ULT) was found to dramatically reducekidney disease progression risks and mortality in patients with stage 3 or higher CKD and hyperuricemia. Patients receiving ULT experienced lower cumulative incidence of composite kidney outcomes, end-stage kidney dis...

A study identifies biological markers that can predict three-month mortality in patients hospitalized with initially mild COVID-19 pneumonia. Researchers developed a predictive score using two renal markers and one inflammatory marker and "were surprised to discover that renal ma...

A study published in the American Journal of Kidney Diseases found that a family history of kidney failure increases the risk of chronic kidney disease progression by 16%. This association was observed even after considering APOL1 risk alleles and social determinants of health. T...

Experts discuss the significant impact of delayed CKD diagnosis on patient quality of life and clinical outcomes in a recent panel discussion. The experts emphasize the need for earlier identification in primary care, noting that delayed diagnosis increases cardiovascular risk an...

A study in the Journal of the American Medical Association shows that the removal of race from the estimated glomerular filtration rate equation has significantly benefitted Black patients, with 27% seeing improved transplant eligibility and 5.3 more transplants per 1,000 Black c...

Organ donations after circulatory death have risen significantly, accounting for 49% of deceased donors in the U.S. last year, up from 2% in 2000, according to a study published in JAMA by NYU Langone Health researchers. This shift, driven by technological advances that preserve ...